Rexulti (brexpiprazole) is an atypical antipsychotic medication approved to treat three conditions: schizophrenia, major depressive disorder (as an add-on to antidepressants), and agitation related to Alzheimer’s disease. It works by fine-tuning the activity of dopamine and serotonin in the brain, two chemical messengers that influence mood, thought patterns, and behavior.
How Rexulti Works in the Brain
Rexulti belongs to a class called serotonin-dopamine activity modulators. Rather than simply blocking or boosting brain chemicals, it acts more like a dial. At dopamine receptors, it functions as a partial agonist, meaning it stimulates the receptor just enough to prevent both too much and too little dopamine signaling. It does the same at one type of serotonin receptor (5-HT1A), which is involved in mood regulation. At another serotonin receptor (5-HT2A), it acts as a blocker, which is thought to help with psychotic symptoms and sleep.
This balanced receptor profile is what makes Rexulti useful across different conditions. In depression, the partial dopamine and serotonin activity can fill gaps left by antidepressants alone. In schizophrenia, it tempers excess dopamine signaling without shutting it down entirely. In Alzheimer’s-related agitation, it calms overactive neural circuits that drive restlessness and aggression.
Approved Uses
Add-On Treatment for Depression
Rexulti is not a standalone antidepressant. It’s prescribed alongside an existing antidepressant when that medication isn’t working well enough on its own. In clinical trials involving patients who had already failed at least one antidepressant, adding Rexulti improved depression scores more than adding a placebo, though the effect size was modest. The number needed to treat for one additional patient to respond was 17, and for one additional patient to reach full remission it was 25. That means most people who take it will see some benefit, but dramatic turnarounds aren’t guaranteed.
For depression, the typical starting dose is 0.5 mg or 1 mg once daily, increasing weekly to a target of 2 mg. The maximum is 3 mg per day. Doses at or below 2 mg showed the best balance of benefit and tolerability in studies.
Schizophrenia
Rexulti is approved for schizophrenia in adults and adolescents aged 13 and older. Treatment usually starts at 1 mg daily for the first four days, increases to 2 mg on days five through seven, then to a target of 2 to 4 mg daily. The maximum dose is 4 mg.
Agitation in Alzheimer’s Disease
In 2023, Rexulti became the first medication the FDA specifically approved to treat agitation symptoms tied to Alzheimer’s dementia. This includes behaviors like pacing, verbal aggression, and physical restlessness that are common in moderate-to-severe Alzheimer’s. Two 12-week trials showed that patients taking 2 mg or 3 mg daily had meaningful reductions in agitation compared to placebo. Trial participants ranged from 51 to 90 years old and had moderate-to-severe cognitive impairment.
The dosing for this use is more gradual: 0.5 mg daily for the first week, 1 mg daily for the second week, then 2 mg daily from day 15 onward. The dose can be increased to 3 mg after at least two more weeks if needed. Rexulti is not approved for as-needed use in these patients; it’s a daily medication.
Common Side Effects
The most frequently reported side effect is akathisia, an uncomfortable inner restlessness that makes you feel like you can’t sit still. In depression trials, about 76 out of every 1,000 people taking Rexulti experienced akathisia, compared to 27 out of 1,000 on placebo. That’s roughly a threefold increase in risk. General restlessness, sleepiness, and insomnia are also more common with Rexulti than with placebo, especially at doses above 2 mg. At higher doses, sleepiness was over seven times more likely than with placebo.
Weight gain is another concern. In short-term depression studies (around six weeks), people gained an average of 3.3 pounds on Rexulti. Over a full year, that average rose to about 7 pounds. Around 30% of people taking Rexulti long-term for depression gained 7% or more of their body weight. For context, these numbers are similar to, and in some cases slightly lower than, those seen with aripiprazole (Abilify), a closely related medication.
In schizophrenia studies, the weight gain pattern was slightly different. Short-term weight gain averaged about 2.6 pounds, while long-term use over a year led to an average gain of roughly 4.6 pounds. About 19% of patients in long-term schizophrenia trials experienced a 7% or greater weight increase.
Important Safety Warnings
Rexulti carries two boxed warnings, the most serious category the FDA uses. The first warns that elderly patients with dementia-related psychosis (not agitation) treated with antipsychotic drugs face an increased risk of death. Rexulti is not approved for dementia-related psychosis. Its Alzheimer’s approval is limited specifically to agitation in patients with a confirmed Alzheimer’s diagnosis. The second boxed warning concerns suicidal thoughts and behaviors, a risk shared by all antipsychotics and antidepressants, particularly in younger adults.
Because Rexulti can affect metabolism, your doctor will likely monitor your fasting blood sugar, cholesterol levels, and weight before starting treatment and periodically afterward. These are standard checks for all medications in this class.
How Long It Stays in Your Body
Rexulti has an unusually long half-life of roughly 91 hours, meaning it takes nearly four days for your body to clear half of a single dose. This has a few practical implications. First, it takes about two to three weeks of daily dosing to reach a stable level in your bloodstream. Second, if you miss a dose, levels won’t drop as dramatically as with shorter-acting medications. Third, if you stop taking it, the drug leaves your system gradually over the course of one to two weeks.
Rexulti is processed in the liver by two specific enzyme pathways. Medications that strongly inhibit either of these pathways can roughly double the amount of Rexulti in your bloodstream. Common examples include certain antifungal medications and some antidepressants. If you take one of these, your prescriber will typically reduce your Rexulti dose to compensate.